ROCEPHIN pdr sol inf 2 g i.v. flac
7680446251056
CH-44625
J01DD04
08.01.3.
Reimbursement limitations:
ROCEPHIN2
• Traitement ultérieur dans la pratique ambulatoire de l'ostéomyélite, des abscès pulmonaires et de l'endocardite.
…
1 / 3
google
Details
- Product number
- 4462504
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio sicca: ceftriaxonum 2 g ut ceftriaxonum natricum pro vitro corresp. natrium 166 mg.
Articles (1)
Rocephin 2 g i.v., Pulver zur Herstellung einer Infusionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRS
|
2.0 G | Substance | Wirkstoff (Principe actif) |
|
PRS
|
- | Substance | WIZUS |
|
PRS
|
166.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 41.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1985
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 44625
- Drug name
- Rocephin, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
- Galenic form
- PULPA
- ATC Code
- J01DD04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 27/05/1982
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ROCEPHIN pdr sol inf 2 g i.v. flac
- Description (DE)
- ROCEPHIN Pulv Inf Lös 2 g i.v. Durchstf
- Market launch
- 27/05/1982
- Narcotic (BTM)
- No